Understanding heart inflammation after COVID-19 vaccination
Comprehensive genomic and inflammatory profiling of vaccine-associated myocarditis
This study is looking at how some people might be more likely to develop myocarditis, a rare heart condition, after getting a COVID-19 vaccine, and it’s inviting kids and adults aged 5 and up who have experienced this condition to help by sharing their genetic information so we can better understand and protect those at risk.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10734071 on NIH RePORTER |
What this research studies
This research investigates the rare but significant heart condition known as myocarditis that can occur after COVID-19 vaccination. By analyzing genetic factors and immune responses, the study aims to identify individuals who may be at higher risk for developing this condition. Participants aged 5 years and older with vaccine-associated myocarditis will undergo genetic testing to uncover potential risk factors. The goal is to improve vaccination strategies and minimize risks for susceptible individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals aged 5 years and older who have experienced myocarditis following COVID-19 vaccination.
Not a fit: Patients who have not received a COVID-19 vaccine or those without a history of myocarditis will likely not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better identification of individuals at risk for vaccine-associated myocarditis, allowing for safer vaccination practices.
How similar studies have performed: While myocarditis is a known complication, this specific genomic approach to understanding vaccine-associated myocarditis is novel and has not been extensively tested in prior research.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Kontorovich, Amy R. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Kontorovich, Amy R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.